[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-462677-105":59,"doc-detail-462677-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","evidence-synthesis-and-mechanism-analysis-of-quercetin-treatment-for-atherosclerosis-a-preclinical-systematic-review-and-meta-analysis","Evidence Synthesis and Mechanism Analysis of Quercetin - Treatment for Atherosclerosis: A Preclinical Systematic Review and Meta-Analysis","","Atherosclerosis seriously threatens human health, and quercetin has attracted interest for its anti-atherosclerotic pharmacological potential. This systematic review and meta-analysis comprehensively evaluated quercetin’s effects and underlying mechanisms using preclinical studies published before 20 January 2025 from PubMed, Embase, Web of Science, CNKI, Wan-fang, and VIP. Study quality was assessed with the CAMARADES list; meta-analyses, sensitivity, subgroup, and publication bias used Stata 12; dose–interval and time–dose analyses explored dosing influences, and trial sequential analyses employed TSA 0.9. Across 22 studies with 421 animals, quercetin reduced aortic plaque area, improved lipid profiles, modulated adhesion and inflammatory mediators, enhanced anti-inflammatory and antioxidant pathways, decreased oxidative stress markers, and regulated targets linked to LXRα, SIRT1, and mTOR, with stronger effects at 25–100 mg/kg over 8–10 weeks.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evidence-synthesis-and-mechanism-analysis-of-quercetin-treatment-for-atherosclerosis-a-preclinical-systematic-review-and-meta-analysis/462677/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evidence-synthesis-and-mechanism-analysis-of-quercetin-treatment-for-atherosclerosis-a-preclinical-systematic-review-and-meta-analysis/462677.png","ImageObject",300,407,{"name":92,"@type":93},"Stanley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-30",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the goal of this study on quercetin for atherosclerosis?","Question",{"text":112,"@type":113},"To comprehensively assess quercetin’s therapeutic effect and potential mechanisms in treating atherosclerosis using a systematic review and meta-analysis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which databases and quality assessment approach were used?",{"text":117,"@type":113},"Preclinical studies were searched in PubMed, Embase, Web of Science, CNKI, Wan-fang, and VIP, and included-study quality was evaluated with the CAMARADES list.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the meta-analysis find about quercetin’s effects?",{"text":121,"@type":113},"Relative to controls, quercetin reduced aortic plaque area, improved lipid measures, downregulated adhesion and pro-inflammatory factors, upregulated IL-10 and antioxidant enzymes (SOD, CAT), lowered MDA, and modulated targets such as LXRα, SIRT1, and mTOR.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},462677,1791266813,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Review  \n# Evidence Synthesis and Mechanism Analysis of Quercetin\n\nTreatment for Atherosclerosis: A Preclinical Systematic Reviewand Meta-Analysis  \nDaiqian Chen† , Jiawei Wang† , Zhiguo Lei, Liping Quand Wenjun Zou *  \nAcademic Editor: AnastasiosLymperopoulos  \nReceived: 24 November 2025  \nRevised: 26 December 2025  \nAccepted: 31 December 2025  \nPublished: 4 January 2026  \nCopyright: © 2026 by the authors.LicenseeMDPI, Basel, Switzerland.This article is an open access articledistributed under the terms andconditions of the Creative CommonsAttribution (CC BY) license .  \nSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China;  \nwangjiawei@stu.cdutcm.edu.cn (J.W.)  \n* Correspondence: zouwenjun@cdutcm.edu.cn† These authors contributed equally to this work.  \n## Abstract\n\nAtherosclerosis seriously endangers human health. Quercetin has drawn attention for itspotential anti-atherosclerotic pharmacological effects. This study aimed to comprehensivelyassess quercetin’s effect and potential mechanism in treating atherosclerosis through asystematic review and meta-analysis. Preclinical studies published before 20 January 2025were searched for in databases including PubMed, Embase, Web of Science, CNKI, Wan-fang, and VIP. The CAMARADES list was used to assess the quality of the included studies.Stata 12 was applied for overall effect, sensitivity, subgroup, and publication bias analyses.Time–dose interval analyses were conducted to explore how quercetin dose and dosingcycle affect intervention effects. Finally, trial sequential analyses were performed usingTSA 0.9 software. A total of 22 studies involving 421 animals were included, with a meanmethodological quality score of 7.73/10 . Meta-analysis showed that relative to the controlgroup, quercetin reduced aortic plaque area, adjusted lipids (lowered TC, TG, and LDL-Cand raised HDL-C), downregulated adhesion factors (e.g., VCAM-1) and pro-inflammatoryfactors (e.g., IL-1β and IL-6), upregulated anti-inflammatory factor IL-10 and antioxidantenzymes (SOD, CAT) while decreasing MDA content, and regulated atherosclerosis-relatedtargets (e.g., LXRα, SIRT1, and mTOR) . Subgroup analyses found model establishment timeand quercetin administration time affected aortic lesion areas, TC, and TG. Time–dose anal-ysis indicated quercetin had better ameliorative effects on atherosclerosis at 25–100 mg/kgwith an 8–10-week intervention. Quercetin significantly improves atherosclerosis andinhibits its occurrence and progression through multiple pathways, such as regulatinglipid metabolism, anti-inflammatory effects, and counteracting oxidative stress. Based oncurrent evidence, quercetin is a potential therapeutic agent for treating atherosclerosis.  \nKeywords: quercetin; atherosclerosis; preclinical evidence; mechanism; meta-analysis  \n## 1. Introduction\n\nAtherosclerosis (AS), which has become the leading cause of cardiovascular mortal-ity worldwide, is a pathological disease characterised by fibrous proliferation of vesselwalls, chronic inflammation, lipid accumulation, and immune disorders. As atheroscleroticplaques continue to develop, the fragile plaques are likely to rupture, leading to acutecardiovascular events including ischaemic stroke and myocardial infarction [1] . Atheroscle-rosisis characterised by high morbidity and mortality rates, with common causative factorsincluding hyperlipidaemia, hypertension, smoking, and diabetes mellitus, but there may  \nbe a gradual restoration of the health of this population with changes in modern diet andexercise habits [2] . The main drugs used clinically for symptomatic treatment includelipid-lowering drugs (statins and niacin), antiplatelet and thrombolytic drugs (aspirin andurokinase), and anticoagulant drugs (warfarin) [3] . These drugs are effective in reduc-ing atherosclerosis by lowering lipid levels, antiplatelet aggregation, and antithrombosis.However, the adverse effects of the drugs after long-term treatment h","cbCaiq2Oh1utno9l","https://ap.wps.com/l/cbCaiq2Oh1utno9l","pdf",5135201,32,"English","# Abstract\n# 1. Introduction","[{\"question\":\"What was the goal of this study on quercetin for atherosclerosis?\",\"answer\":\"To comprehensively assess quercetin’s therapeutic effect and potential mechanisms in treating atherosclerosis using a systematic review and meta-analysis.\"},{\"question\":\"Which databases and quality assessment approach were used?\",\"answer\":\"Preclinical studies were searched in PubMed, Embase, Web of Science, CNKI, Wan-fang, and VIP, and included-study quality was evaluated with the CAMARADES list.\"},{\"question\":\"What did the meta-analysis find about quercetin’s effects?\",\"answer\":\"Relative to controls, quercetin reduced aortic plaque area, improved lipid measures, downregulated adhesion and pro-inflammatory factors, upregulated IL-10 and antioxidant enzymes (SOD, CAT), lowered MDA, and modulated targets such as LXRα, SIRT1, and mTOR.\"}]","Evidence Synthesis and Mechanism Analysis of Quercetin - Treatment for Atherosclerosis: A Preclinical Systematic Review and Meta-Analysis | PDF",1790764863,81,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/a0016294bdf324d65381361c3922a15c.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/940a4be2b3192ff17fbb56ea95171c20.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/b72a2ed3da195a7b0f021845ddad4933.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/b43cd3f8829295230465b4d8ac0a3a31.webp",980,1385]